Source: PRWeb

Press Release: MP Biomedicals : MP Biomedicals Announces Investment in a Biotechnology Campus in Solon, Ohio

MP Biomedicals announces the construction of a 75,000 square foot manufacturing facility in Solon, Ohio to be used for current Good Manufacturing Practices (cGMP) manufacturing of production biochemicals, cell culture media, liquid formulation, powder compounding, and other custom...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Huanjie Wang's photo - Chairman & CEO of MP Biomedicals

Chairman & CEO

Huanjie Wang

CEO Approval Rating

84/100

Read more